Only show
results from:





Sort results by:

Display preferences

45 results sorted by relevancy Results per page:
DiaSys Corporation Signs Agreement in Principle to Acquire Biocheck, Inc., and EverNew Biotech Inc.; Acquisitions Expected To Dramatically Increase Growth.
Business Wire; Jan 5, 2005; 700+ Words ...capital stock of Biocheck, Inc. and EverNew Biotech...accounts. Biocheck, Inc., offers a broad...and other areas. Biocheck manufactures according...not disclosed. Biocheck and EverNew Biotech...proprietary medical laboratory equipment, consumables...healthcare and veterinary ...
Axela Biosensors to Develop Commercial Biomarker Assays With BioCheck's Antibody Reagents.
PR Newswire; May 7, 2007; 700+ Words ...TM) System, a bench-top laboratory platform that delivers simple...VenGrowth Private Equity Partners Inc., one of Canada's premier...axelabiosensors.com/. About BioCheck BioCheck, Inc. is a leading provider of high...
N-VIRO INTERNATIONAL CORPORATION ANNOUNCES 1995 YEAR END RESULTS
PR Newswire; Apr 10, 1996; 700+ Words ...closed regional sales offices, sold its wholly owed subsidiary, N-Viro Worldwide, plans to sell its laboratory, BioCheck Laboratories, Inc., entered into an agreement to sell its Honolulu, Hawaii facility and arranged a joint venture for...
N-VIRO INTERNATIONAL REPORTS IMPROVED SECOND QUARTER EARNINGS
PR Newswire; Jul 31, 1996; 700+ Words ...wholly owned subsidiary, N-Viro Worldwide, the Company has closed regional sales offices; sold its laboratory, BioCheck Laboratories, Inc.; has negotiated to codevelop its Honolulu, Hawaii, facility; and arranged a joint venture for...
NVIC RELEASES 1ST QUARTER 1996 EARNINGS
PR Newswire; Apr 30, 1996; 700+ Words ...closed regional sales offices; sold its wholly owned subsidiary, N-Viro Worldwide; plans to sell its laboratory, BioCheck Laboratories, Inc.; has negotiated to sell its Honolulu, Hawaii facility; and arranged a joint venture for its Fort...
Reportlinker Adds Laboratory Chemical Reagents - A Global Market Review.
PR Newswire; Nov 17, 2009; 700+ Words ...vertical market analyses. LABORATORY CHEMICAL REAGENTS BMR...Licensing Agreement with BioCheck 19 SAFC Establishes...23 EMD Chemicals, Inc. (US) 23 GE Healthcare...Mallinckrodt Baker, Inc (US) 24 Mediatech, Inc. (US) 24 Meridian...Japan) 25 Clontech Laboratories Inc 25 Wako ...
Laboratory Chemical Reagents - A Global Market Review.
M2 Presswire; Nov 23, 2009; 700+ Words ...Research and Markets: Laboratory Chemical Reagents - A...Review" by BizAcumen, Inc. Our reports are designed...Licensing Agreement with BioCheck - SAFC Establishes Two...US) - EMD Chemicals, Inc. (US) - GE Healthcare...Mallinckrodt Baker, Inc (US) - Mediatech...
Research and Markets: Laboratory Chemical Reagents - A Global Market Review.
Business Wire; Nov 23, 2009; 700+ Words ...research/1948b1/laboratory_chemica) has announced...Review" by BizAcumen, Inc. Our reports are designed...Licensing Agreement with BioCheck * SAFC Establishes Two...US) * EMD Chemicals, Inc. (US) * GE Healthcare...Mallinckrodt Baker, Inc (US) * Mediatech...
OXIS International Identifies New Biomarker for Early Detection of Cardiovascular Disease.
Business Wire; Jan 23, 2007; 700+ Words ...expect Oxis's and BioCheck's broad array of...trends. About OXIS and BioCheck: OXIS International, Inc. develops technologies...distributors and government laboratories. OXIS has acquired a 51% interest in BioCheck, with the option to...
Oxis International to Present at Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference.
Business Wire; May 14, 2007; 700+ Words ...OXIS International Inc (OTCBB: OXIS...independent animal fertility laboratories. ERGO increased sperm...days. About OXIS and BioCheck: OXIS International, Inc. develops technologies...acquired a 51 interest in BioCheck, with the option to...
Health Values of Mushrooms Containing Compound L-Ergothioneine Discussed on CNN.com.
Business Wire; Nov 15, 2007; 700+ Words ...2007/HEALTH, "Laboratory reports and animal studies...from Oxis International Inc (OXIS). The OXIS...Oxis International, Inc. "ERGO cannot be synthesized...2007. About OXIS and BioCheck: Oxis International, Inc. develops technologies...distributors and government laboratories. OXIS ...
Oxis International Finalizes First Commercial Sale of L-Ergothioneine to Minitube of America.
Business Wire; Oct 24, 2007; 700+ Words ...Golden Gourmet Mushrooms Inc. added, "I am looking...study." About OXIS and BioCheck: OXIS International, Inc. develops technologies...distributors and government laboratories. OXIS has acquired a 51% interest in BioCheck, with the option to...
Oxis International Receives $1 Million Up-Front Payment from Licensing Deal with Synvista Therapeutics.
Business Wire; Aug 22, 2007; 700+ Words ...formerly known as Alteon, Inc. Under the terms of...2008. About OXIS and BioCheck: OXIS International, Inc. develops technologies...distributors and government laboratories. OXIS has acquired a 51% interest in BioCheck, with the option to...
OXIS Out-licensed Drug BXT 51072 to Be Developed by Synvista for the Treatment of Psoriasis.
Business Wire; Jan 18, 2008; 700+ Words ...Oxis International, Inc.," stated Marvin S...antioxidants." About OXIS and BioCheck: Oxis International, Inc. develops technologies...distributors and government laboratories. OXIS has acquired a 51% interest in BioCheck, with the option to...
Oxis International Biomarker Shown Effective in Assessing Antioxidant Potential of Dietary Supplements.
Business Wire; Nov 7, 2007; 700+ Words ...Oxis International Inc. "Nutritional supplements...ingredients. About OXIS and BioCheck: Oxis International, Inc. develops technologies...distributors and government laboratories. OXIS has acquired a 51% interest in BioCheck, with the option to...
OXIS International Retains Internationally Recognized Expert on Anti-Oxidants and L-Ergothioneine as Consultant.
Business Wire; Feb 1, 2007; 700+ Words ...UK. About OXIS and BioCheck: OXIS International, Inc. develops technologies...distributors and government laboratories. OXIS has acquired a 51% interest in BioCheck, with the option to...the remaining 49%. BioCheck is a leading provider...
OXIS International To Submit Promising BioDefense Compounds For Evaluation to Key Government Agencies.
Business Wire; Feb 22, 2007; 700+ Words ...Novartis. About OXIS and BioCheck: OXIS International, Inc. develops technologies...distributors and government laboratories. OXIS has acquired a 51% interest in BioCheck, with the option to...the remaining 49%. BioCheck is a provider of high...
Oxis Dietary Supplement L-Ergothioneine Provides New Therapeutic Strategy for the Prevention and Treatment of Chronic Inflammatory Diseases.
Business Wire; Jul 2, 2007; 700+ Words ...Oxis International Inc (OTCBB: OXIS), a...diseases." About OXIS and BioCheck: OXIS International, Inc. develops technologies...distributors and government laboratories. OXIS has acquired a 51% interest in BioCheck, with the option to...
Alteon and OXIS International Expand Licensing Deal to Include Exclusive Rights of Organoselenium Compounds for All Indications.
PR Newswire; Apr 9, 2007; 700+ Words ...OXIS OXIS International, Inc. develops technologies...distributors and government laboratories. OXIS holds a controlling interest in BioCheck, Inc., a provider of high...and fertility hormones. BioCheck operates a 15,000 square...
Expand Licensing Deal Between Alteon and OXIS International to Include Exclusive Rights of Organoselenium Compounds for All Indications.
M2 Presswire; Apr 12, 2007; 700+ Words ...OXIS OXIS International, Inc. develops technologies...distributors and government laboratories. OXIS holds a controlling interest in BioCheck, Inc., a provider of high...and fertility hormones. BioCheck operates a 15,000 square...
45 results: 1 | 2 | 3